The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Induction of Tumors in Mice by Genomic Hypomethylation
Abstract
Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 ( Dnmt1 ) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced DNA methylation (hypomethylation) in mice increases the risk of aneuploidy and cancer (Gaudet et al., 2003)”
From The Aging Epigenome (2016) · cites this paper as Gaudet et al., 2003
In the citing paper
“Indeed, the global DNA hypomethylation, especially occurring on intragenic regions, is a general feature of most tumours [35][36][37] .”
From Intragenic DNA methylation prevents spurious transcription initiation (2017) · cites this paper as [36]
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Self-citationThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Self-citationHypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Self-citationXu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
Walsh, C. P., Chaillet, J. R., & Bestor, T. H. (1998) · Nature Genetics · doi:10.1038/2413 · Cited by 1,105
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 954
Self-citation
Research works printed but not linked: 3
- S. Cory, D. L. Vaux, A. Strasser, A. W. Harris, J. M. Adams, Cancer Res.59 (suppl.), 1685s (1999).
- E. Wainfan, L. A. Poirier, Cancer Res.52, 2071s (1992).
- V. Zagonelet al., Leukemia7 (suppl. 1), 30 (1993).
Cited by
Items 801–900 of 1,001
Reduced LINE-1 methylation is associated with arsenic-induced genotoxic stress in children
Bandyopadhyay, A. K., Paul, S., Adak, S., & Giri, A. K. (2016) · BioMetals · doi:10.1007/s10534-016-9950-4 · Cited by 26
“Genomic hypomethylation have been associated with chromosomal instability (Gaudet et al. 2003).”
BackgroundEpigenetic regulation of RTK signaling
Spangle, J. M., & Roberts, T. M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1546-0 · Cited by 27
DNA Methylation and Cancer-associated Genetic Instability
Ehrlich, M. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_13 · Cited by 27
Regulation of CRABP-II expression by MycN in Wilms tumor
Gupta, A., Kessler, P., Rawwas, J., & Williams, B. R. G. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.09.029 · Cited by 26
Richterʼs Syndrome: Biology and Therapy
Yee, K. W. L., OʼBrien, S. M., & Giles, F. J. (2005) · The Cancer Journal · doi:10.1097/00130404-200505000-00001 · Cited by 30
Tryndyak, V., Kovalchuk, O., & Pogribny, I. P. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.05.019 · Cited by 26
Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation
Hatano, Y., Semi, K., Hashimoto, K., Lee, M. S., Hirata, A., Tomita, H., Kuno, T., Takamatsu, M., Aoki, K., Taketo, M. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv060 · Cited by 25
DNA Methylation Changes in Cancer
Toyota, M., & Yamamoto, E. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387685-0.00014-7 · Cited by 26
Epigenetic regulation of DNMT1 gene in mouse model of asthma disease
Verma, M., Chattopadhyay, B., & Paul, B. N. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2317-1 · Cited by 26
“Epigenetic is an important, alternative mechanism of gene regulation that is independent of the nucleotide sequence of DNA, and it has been shown to be related to the development of several diseases [4, 5]; including cancer, syndromes involving chromosomal instabilities, mental retardation, immunodeficiency and autoim…”
BackgroundEpigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
Vannucchi, A. M., Guglielmelli, P., Rambaldi, A., Bogani, C., & Barbui, T. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00827.x · Cited by 25
“Mitotic recombination and chromosomal rearrangements can be facilitated by global DNA hypomethylation [73], as suggested by the observation that mice carrying a diffuse genome hypomethylation as a result of a hypomorphic DNA methyltransferase 1 (DNMT1) allele develop aggressive T-cell lymphomas associated with a high…”
BackgroundVallebona, P. S., Matteucci, C., & Spadafora, C. (2011) · Cancers · doi:10.3390/cancers3011141 · Cited by 26
“genomic hypomethylation in tumor formation [57].”
Huang, J. Y., Butler, L. M., Wang, R., Jin, A., Koh, W., & Yuan, J. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0594 · Cited by 29
“Global DNA hypomethylation has been linked with genomic instability (49) and tumorigenesis (50, 51).”
Samuelsson, J., Dumbović, G., Rivera, C. P., Moreta-Moraleda, C., Alibés, A., Ruiz‐Larroya, T., Gimenez‐Bonafé, P., Alonso, S., Forcales, S. V., & Perucho, M. (2016) · Epigenomes · doi:10.3390/epigenomes1010002 · Cited by 25
Yamamura, K., Kosumi, K., Baba, Y., Harada, K., Gao, F., Zhang, X., Zhou, L., Kitano, Y., Arima, K., Kaida, T., et al. (2017) · Surgery Today · doi:10.1007/s00595-017-1539-1 · Cited by 25
Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia
Vicente‐Dueñas, C., González‐Herrero, I., Sehgal, L., García‐Ramírez, I., Rodríguez-Hernández, G., Pintado, B., Blanco, Ó., Criado, F. J. G., Cenador, M. B. G., Green, M. R., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0192-z · Cited by 26
Tsang, M., Gantchev, J. K., Netchiporouk, E., Moreau, L., Ghazawi, F. M., Glassman, S. J., Sasseville, D., & Litvinov, I. V. (2018) · Oncotarget · doi:10.18632/oncotarget.26479 · Cited by 28
“Remarkably, it has been demonstrated that 80% of mice with a knockdown of DNMT1, which results in a hypomethylated genome, develop mature T-cell lymphomas [50].”
BackgroundDysregulation of the Epigenome in Human Breast Cancer
Sandhu, R., Roll, J. D., Rivenbark, A. G., & Coleman, W. B. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.003 · Cited by 26
Dhillon, V. S., Young, A. R., Husain, S. A., & Aslam, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601567 · Cited by 25
Clinical studies with fetal hemoglobin—enhancing agents in sickle cell disease
Saunthararajah, Y., & DeSimone, J. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.08.003 · Cited by 26
Gastric Cancer Signaling Pathways and Therapeutic Applications
Wu, M., Yuan, S., Liu, K., Wang, C., & Wen, F. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241271935 · Cited by 24
“109 – 111 This is the original driver of gastric carcinogenesis.”
BackgroundPhenolic compounds and epigenetic mechanisms regulating gene expression: effects on human health
Lorente‐Cebrián, S., Costa, A. G. V., Castillo-Rivas, J. A., Castro, M., Arbonés-Mainar, J. M., Goñi, S., Remón, S., Aranaz, P., López, V., Martín‐Burriel, I., et al. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01105-7 · Cited by 35
“However, some authors have suggested the induction of tumors due to severe DNMT inhibition and the presence of hypo-methylated DNA [30, 38], which warrants further studies to fully clarify these potentially negative findings, particularly with high doses of polyphenols.”
Bacteria-related changes in host DNA methylation and the risk for CRC
Sobhani, I., Rotkopf, H., & Khazaie, K. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1800898 · Cited by 26
“While treatment with 5-azadeoxycytidine reduces tumor burden in mouse models of hereditary polyposis,(66) DNMT1 deficiency predisposes mice to developing lymphomas.(67) Additional studies indicate that, while DNA hypermethylation of specific loci drives CRC tumorigenesis,(68,69) genome-wide hypomethylation is associat…”
BackgroundEpigenetics Regulates Antitumor Immunity in Melanoma
Chen, Y., Yi, X., Sun, N., Guo, W., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868786 · Cited by 27
Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis.
Santos, J., & Ribeiro, M. L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i30.9021 · Cited by 25
Role of Hypermethylation on Carcinogenesis in the Pancreas
Kuroki, T., Tajima, Y., & Kanematsu, T. (2004) · Surgery Today · doi:10.1007/s00595-004-2858-6 · Cited by 26
Gene Regulation by Methylation
Mueller, W. C., & von Deimling, A. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-31206-2_13 · Cited by 25
Ward, E., Varešlija, D., Charmsaz, S., Fagan, A., Browne, A. L., Cosgrove, N. S., Cocchiglia, S., Purcell, S. P., Hudson, L., Das, S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2615 · Cited by 26
“org Clin Cancer Res; 24(15) August 1, 2018 3695”
BackgroundInfluentialRestricted mobility of Dnmt1 in preimplantation embryos: implications for epigenetic reprogramming
Grohmann, M., Spada, F., Schermelleh, L., Alenina, N. V., Bäder, M., Cardoso, M. C., & Leonhardt, H. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-18 · Cited by 24
“Since mice expressing reduced levels of Dnmt1 protein already show severe genomic hypomethylation [22], even partial cytoplasmic retention of Dnmt1 could account for global passive demethylation and epigenetic reprogramming.”
BackgroundSelf-citationCornelius, M. G., Wörth, C. C. T., Kliem, H., Wießler, M., & Schmeiser, H. H. (2005) · Electrophoresis · doi:10.1002/elps.200410405 · Cited by 24
Histone Methylation and the Initiation of Cancer
Huang, S. (2008) · CRC Press eBooks · doi:10.1201/9781420045802.ch8 · Cited by 25
Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas
Kurmasheva, R. T., Peterson, C. A., Parham, D. M., Chen, B., McDonald, R. E., & Cooney, C. A. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20285 · Cited by 24
Park, C. W., Park, J., Kren, B. T., & Steer, C. J. (2006) · Genomics · doi:10.1016/j.ygeno.2006.04.007 · Cited by 25
“In fact, partial or complete lack of DNA methyltransferase activity results in dramatic changes associated with those biological processes [13–15].”
BackgroundThe New Field Of Epigenomics: Implications for Cancer and Other Common Disease ResearchPreprint
Bjornsson, H. T., Cui, H., Gius, D. R., Fallin, M. D., & Feinberg, A. P. (2004) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2004.69.447 · Cited by 25
“Hypomethylation also leads to chromosomal instability, and this has been shown to promote tumor formation in a mouse model (Gaudet et al. 2003).”
BackgroundEpigenetics in BIOLOGY and MEDICINE
(2008) · CRC Press eBooks · doi:10.1201/9781420007077 · Cited by 27
Mechanism of Action of Lactic Acid on Histones in Cancer
Sgarra, R., Battista, S., Cerchia, L., Manfioletti, G., & Fedele, M. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0190 · Cited by 25
Research progress of DNA methylation in colorectal cancer (Review)
Wang, Y., Wang, C., Zhong, R., Wang, L., & Sun, L. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13278 · Cited by 28
“Early studies revealed that tumor cells are extensively hypomethylated at the genome‑wide level, resulting in the activation of proto‑oncogenes and an increase in genomic instability (31).”
BackgroundPotocki, L., Lewińska, A., Klukowska‐Rötzler, J., Bugno‐Poniewierska, M., Koch, C., Mählmann, K., Janda, J., & Wnuk, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.026 · Cited by 23
“It has been suggested that the global DNA hypomethylation status may contribute to cancer progression by promoting chromosomal instability [59].”
BackgroundDey, C., Raina, K., Haridhasapavalan, K. K., Thool, M., Sundaravadivelu, P. K., Adhikari, P., Gogoi, R., & Thummer, R. P. (2021) · Recent Advances in iPSC Technology · doi:10.1016/b978-0-12-822231-7.00011-4 · Cited by 23
Selective chemical tracking of Dnmt1 catalytic activity in live cells
Stankevičius, V., Gibas, P., Masiulionytė, B., Gasiulė, L., Masevičius, V., Klimašauskas, S., & Vilkaitis, G. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.008 · Cited by 24
“Loss of the DNMT1 function is directly linked to tumorigenesis and chromosomal instability (Eden et al., 2003; Gaudet et al., 2003), whereas DNMT3B mutations cause a severe autosomal disease, called ICF syndrome (Hansen et al.”
BackgroundZhao, N., Lai, C., Wang, Y., Dai, S., & Gu, H. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189096 · Cited by 33
Kutay, H., Klepper, C., Wang, B., Hsu, S.-H., Datta, J., Yu, L., Zhang, X., Majumder, S., Motiwala, T., Khan, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041949 · Cited by 23
“In contrast, another hypomprphic (Dnmt1) mice that express only 10% activity of the Dnmt1 mice develop spontaneous hepatocellular carcinoma with age [18,19].”
BackgroundDi, J., Han, X., Wen-ye, G., Wang, Y., Zheng, Q., Zhang, P., Wu, H., & Zhu, Z. (2011) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1000422 · Cited by 24
“Animal studies have shown that experimentallyinduced hypomethylation can lead to cancer development at multiple sites (Wilson et al., 1984; Thomas and Williams, 1992; Gaudet et al., 2003), indicating the causal role of global DNA hypomethylation in cancer development.”
Honeybees and cell lines as models of DNA methylation and aging in response to diet
Ford, D. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.010 · Cited by 24
In vitro transformation of mesenchymal stem cells induces gradual genomic hypomethylation
Wild, L., Funes, J. M., Boshoff, C., & Flanagan, J. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq080 · Cited by 23
Schoof, C. R. G., Izzotti, A., Jasiulionis, M. G., & Vasques, L. R. (2015) · BioMed Research International · doi:10.1155/2015/634749 · Cited by 23
“They were transfected into cells with Fugene 6 (Promega), and culture was maintained in medium with 4 ug/mL puromycin through 14 days in order to select transfected resistant cells, followed by RNA and total protein extraction.”
MethodRole of epigenome in tumorigenesis and drug resistance
Hu, Q., & Baeg, G. H. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.022 · Cited by 25
Ma, X., Jia, C., Chu, M., Fu, D., Lei, Q., Ding, X., Wu, X., Guo, X., Pei, J., Bao, P., et al. (2019) · Genes · doi:10.3390/genes10120970 · Cited by 24
“It is generally considered to be a type of silent marker that can be stably inherited to the next generation, especially in the inactivation of the X chromosome [15], genomic imprinting [16], and ensuring the stability of transposons in the genome [17].”
BackgroundThe epigenome as a molecular marker and target
Gius, D. R., Bradbury, C. M., Sun, L., Awwad, R. T., Huang, L., Smart, D. D., Bisht, K. S., Ho, A. S., & Nguyen, P. (2005) · Cancer · doi:10.1002/cncr.21395 · Cited by 23
“Since the initial discovery of altered methylation in human cancer,(5) a host of epigenetic alterations has been found, including global hypomethylation, gene hypomethylation and hypermethylation, and loss of imprinting.(6,7) Overexpression of DNMT and increased methylation of promoters of tumor suppressor genes and t…”
BackgroundGertych, A., Oh, J. H., Wawrowsky, K., Weisenberger, D. J., & Tajbakhsh, J. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-11 · Cited by 23
“Especially, the loss of global DNA methylation at heterochromatic areas of the genome that harbor highly repetitive DNA sequences such as highly abundant Alu repeats, transposable long interspersed nuclear elements (LINEs) and satellite DNAs can be associated with multiple risks towards genome instability [8,88]; thro…”
BackgroundInfluence of tissue, age, and environmental quality on DNA methylation in Alligator mississippiensis
Parrott, B. B., Bowden, J. A., Kohno, S., McCoy, J. A., Hale, M. D., Bangma, J., Rainwater, T. R., Wilkinson, P. M., Kucklick, J. R., & Guillette, L. J. (2014) · Reproduction · doi:10.1530/rep-13-0498 · Cited by 29
Chromatin effects in nutrition, cancer, and obesity
Garfinkel, M. D., & Ruden, D. M. (2003) · Nutrition · doi:10.1016/j.nut.2003.09.010 · Cited by 24
Modifying the Epigenome as a Therapeutic Strategy in Myelodysplasia
Garcia‐Manero, G. (2007) · Hematology · doi:10.1182/asheducation-2007.1.405 · Cited by 25
“Animals in which DNMT activity is depleted both by genetic targeting and pharmacologic manipulation have been shown to develop secondary tumors probably related to the development of genomic instability.(36) The experience at MDACC with several hundred patients treated with either 5-azacitidine or 5-aza-2′-deoxycitidi…”
BackgroundSpanu, A., Schillaci, O., & Madeddu, G. (2005) · PubMed · Cited by 29
Wang, K.-Y., Chen, S. C.-C., & Shen, C.-K. J. (2014) · Epigenomics · doi:10.2217/epi.14.21 · Cited by 24
Sun, D., Layman, T. S., Jeong, H., Chatterjee, P., Grogan, K. E., Merritt, J. R., Maney, D. L., & Yi, S. V. (2021) · Molecular Ecology · doi:10.1111/mec.15793 · Cited by 24
“Hypomethylation is known to activate TEs (Rodríguez-Paredes & Esteller, 2011), further increasing TE insertion (Gaudet et al., 2003; Howard et al., 2007).”
BackgroundA long intergenic non-coding RNA regulates nuclear localization of DNA methyl transferase-1
Jones, R., Wijesinghe, S. N., Wilson, C., Halsall, J. A., Liloglou, T., & Kanhere, A. (2021) · iScience · doi:10.1016/j.isci.2021.102273 · Cited by 24
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
Jung, I., An, J., & Ko, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030654 · Cited by 24
The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk
Ajabnoor, G. (2023) · Medicina · doi:10.3390/medicina59071338 · Cited by 28
“Therefore, global hypomethylation related to cancer development and progression occurs through oncogene activation and chromosomal abnormalities [167,168].”
BackgroundBaba, Y., Yasuda, N., Bundo, M., Nakachi, Y., Ueda, J., Ishimoto, T., Iwatsuki, M., Miyamoto, Y., Yoshida, N., Oshiumi, H., et al. (2023) · Cancer Science · doi:10.1111/cas.16007 · Cited by 24
Baba, Y., Ishimoto, T., Harada, K., Kosumi, K., Murata, A., Miyake, K., Hiyoshi, Y., Kurashige, J., Iwatsuki, M., Iwagami, S., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4445-z · Cited by 22
Folate deficiency regulates expression of DNA polymerase β in response to oxidative stress
Unnikrishnan, A., Prychitko, T., Patel, H., Chowdhury, M. E., Pilling, A. B., Ventrella-Lucente, L. F., Papakonstantinou, E. V., Cabelof, D. C., & Heydari, A. R. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.003 · Cited by 22
Brown, J. D., Picuillo, V., & O'Neill, R. J. W. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.095273 · Cited by 22
“Indeed, mutations in the genes and/or proteins involved in the establishment and maintenance of methylation patterns during mouse development result in embryonic lethality, loss of imprinting (for review, see [10]), an increased rate of chromosomal instability, gene rearrangements and tumor susceptibility [11, 12], as…”
BackgroundNutrition, Epigenetic Mechanisms, and Human Disease
Maulik, N., & Maulik, G. (2010) · CRC Press eBooks · doi:10.1201/b10449 · Cited by 83
Shiba‐Ishii, A. (2021) · Pathology International · doi:10.1111/pin.13147 · Cited by 23
Folate supplementation limits the tumourigenesis in rodent models of gliomagenesis
Cartron, P., Hervouet, É., Debien, E., Olivier, C., Pouliquen, D., Ménanteau, J., Loussouarn, D., Martin, S. A., Campone, M., & Vallette, F. M. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.01.002 · Cited by 25
Bachman, A. N., Curtin, G. M., Doolittle, D. J., & Goodman, J. I. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj179 · Cited by 21
“These mice developed aggressive T-cell lymphomas which were linked to the development of chromosomal instability and the inappropriate activation of oncogenes (Gaudet et al., 2003).”
BackgroundMBD2 deficiency does not accelerate p53 mediated lymphomagenesis
Sansom, O. J., Bishop, S. M., Bird, A. P., & Clarke, A. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208166 · Cited by 22
“However, recent murine studies have raised concerns about the effects of proposed antitumour strategies that reduce DNMT1 as global genomic hypomethylation has been shown to induce lymphomas with increased genomic instability (Eden et al., 2003; Gaudet et al., 2003).”
BackgroundInfluentialChan, T. A.-T., & Baylin, S. B. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2011_165 · Cited by 28
Regulation of malignant progression by the hypoxia-sensitive transcription factors HIF-1α and MTF-1
Murphy, B. J. (2004) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2004.04.009 · Cited by 27
Jeon, Y., Kwak, S.-S., Cheong, S.-A., Seong, Y. H., & Hyun, S. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.12-0105 · Cited by 21
“Interfering with the proper establishment of methylation can result in tumorigenesis and death [11, 16, 31].”
BackgroundHusni, R. E., Shiba‐Ishii, A., Nakagawa, T., Dai, T., Kim, Y., Hong, J., Sakashita, S., Sakamoto, N., Sato, Y., & Noguchi, M. (2019) · Oncotarget · doi:10.18632/oncotarget.26676 · Cited by 21
“On the other hand, global hypomethylation of genomic DNA can lead to genetic alteration [17] as well as overexpression of proto-oncogenes and growth factors, [18] resulting in tumorigenesis.”
BackgroundAlexandraki, A., & Strati, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214042 · Cited by 21
“Our data further support that use of DAC can be a “double-edged sword”, as previously characterized by others [51], as it can result in off-target effects.”
MethodMatsuda, Y., Yamashita, S., Lee, Y., Niwa, T., Yoshida, T., Gyobu, K., Igaki, H., Kushima, R., Lee, S., Wu, M., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9955-4 · Cited by 24
Spadafora, C. (2016) · BioEssays · doi:10.1002/bies.201500197 · Cited by 21
Down-regulation of IFITM1 and its growth inhibitory role in cervical squamous cell carcinoma
Zheng, W., Zhao, Z., Yi, X., Zuo, Q., Li, H., Guo, X. Q., Li, D., He, H., Pan, Z., Fan, P., et al. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0456-0 · Cited by 21
Epigenetic dysregulation of key developmental genes in radiation‐induced rat mammary carcinomas
Daino, K., Nishimura, M., Imaoka, T., Takabatake, M., Morioka, T., Nishimura, Y., Shimada, Y., & Kakinuma, S. (2018) · International Journal of Cancer · doi:10.1002/ijc.31309 · Cited by 21
Transgenerational inheritance of impaired larval T cell development in zebrafish
Iwanami, N., Lawir, D.-F., Sikora, K., O’Meara, C. P., Takeshita, K., Schorpp, M., & Boehm, T. L. J. (2020) · Nature Communications · doi:10.1038/s41467-020-18289-9 · Cited by 22
Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB
Guan, H., Mi, B., Li, Y., Wu, W., Tan, P., Fang, Z., Li, J., Zhang, Y., & Li, F. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.006 · Cited by 26
One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of Chemoprevention
Hanley, M. P., & Rosenberg, D. W. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-015-0028-8 · Cited by 20
de Cáceres, I. I., & Cairns, P. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0081-9 · Cited by 21
“Indeed, methylation markers are ideally suited for detecting cancer at early stages [21].”
BackgroundHenry, R. A., Mancuso, P., Kuo, Y., Tricarico, R., Tini, M., Cole, P. A., Bellacosa, A., & Andrews, A. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00841 · Cited by 22
Arroyo, M. D. C. G., Hastert, F. D., Zhadan, A., Schelter, F., Zimbelmann, S., Rausch, C., Ludwig, A. K., Carell, T., & Cardoso, M. C. (2022) · Nature Communications · doi:10.1038/s41467-022-32799-8 · Cited by 20
Kuppusamy, S. P., Kaiser, J. P., & Wesselkamper, S. C. (2015) · International Journal of Toxicology · doi:10.1177/1091581815599350 · Cited by 20
Hao, D., Xu, W., Wang, H., Du, L.-F., Yang, J., Zhao, X., & Sun, C. (2012) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2012.06.006 · Cited by 21
Chen, H., Yang, C., Cheng, J., Tsai, K., Fu, T., Liou, H., Tseng, H., Lee, J., Li, G., Wang, J., et al. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12381 · Cited by 20
Global demethylation in loss of imprinting subtype of wilms tumor
Ludgate, J. L., Mée, G. L., Fukuzawa, R., Rodger, E. J., Weeks, R. J., Reeve, A. E., & Morison, I. M. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22017 · Cited by 24
“In another study, mice expressing only 10% of Dnmt1, the key maintenance methyltransferase in mammals, displayed genome-wide hypomethylation in all tissues and developed very aggressive T cell lymphomas as well as chromosomal instability (Gaudet et al., 2003).”
BackgroundRFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation
Wu, B.-K., Mei, S.-C., & Brenner, C. (2014) · Cell Cycle · doi:10.4161/15384101.2014.950886 · Cited by 20
“Conversely, deficient DNMT1 causes global hypomethylation without site-specific hypermethylation.(18,19) Thus, changing the expression of DNMT1 alone is insufficient to recapitulate the linked and vectorially opposite epigenetic alterations observed in cancer.”
BackgroundBrown, J. D., Golden, D. A., & O'Neill, R. J. W. (2008) · Genomics · doi:10.1016/j.ygeno.2007.12.001 · Cited by 19
Shen, R. R. (2006) · Blood · doi:10.1182/blood-2006-02-001354 · Cited by 20
Regulation of DNA methyltransferase 1
Spada, F., Rothbauer, U., Zolghadr, K., Schermelleh, L., & Leonhardt, H. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.011 · Cited by 23
Self-citationWu, Y. S., Lee, Z. Y., Chuah, L., Mai, C., & Ngai, S. C. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180430130248 · Cited by 29
Hong, Y., Hong, S., Oh, Y., Shin, S., Choi, S. S., & Kim, W. J. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0034-0 · Cited by 19
Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival
Li, B., Wang, Y., Xu, Y., Liu, H., Bloomer, W., Zhu, D., Amos, C. I., Fang, S., Lee, J. E., Li, X., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31243 · Cited by 19
“The deletion or reduction of DNMT1 leads to substantial genome-wide hypomethylation and chromosomal instability in human tumors.(49) Recent studies have identified associations between DNMT1 dysregulation, melanomagenesis and melanocyte malignant transformation.”
TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion
Yu, S., Yin, Y., Hong, S., Cao, S., Huang, Y., Chen, S., Liu, Y., Guan, H., Zhang, Q., Li, Y., et al. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3909610 · Cited by 19
“It is closely associated with tumor initiation and progression [6, 7].”
BackgroundAlu Methylation and Risk of Cancer: A Meta-analysis
Ye, D., Jiang, D., Zhang, X., & Mao, Y. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.03.002 · Cited by 19
Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice
Oghamian, S., Sodir, N. M., Bashir, M. U., Shen, H., Cullins, A. E., Carroll, C., Kundu, P., Shibata, D. K., & Laird, P. W. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr039 · Cited by 18
Sézary Syndrome: Clinical and Biological Aspects
Kohnken, R. A., Fabbro, S. K., Hastings, J., Porcu, P., & Mishra, A. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0351-0 · Cited by 23
DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis
Udali, S., Santis, D. D., Ruzzenente, A., Moruzzi, S., Mazzi, F., Beschin, G., Tammen, S. A., Campagnaro, T., Pattini, P., Olivieri, O., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2017.00229 · Cited by 19
“Global DNA hypomethylation is thought to play an important role in carcinogenesis by inducing chromosomal instability and the global loss of imprinting (Gaudet et al., 2003; Holm et al., 2005; Wilson et al., 2007; Ehrlich and Lacey, 2013).”
BackgroundRecent Advances in Molecular Diagnosis and Therapy of Gastric Cancer
Chen, J., Röcken, C., Malfertheiner, P., & Ebert, M. P. (2004) · Digestive Diseases · doi:10.1159/000083602 · Cited by 19
“Apart from genetic alterations, epigenetic alterations have recently drawn increasing attention in gastric carcinogenesis and metastasis. Cancer-related epigenetic alterations include a global genomic hypomethylation and a dense hypermethylation of the CpG islands in gene regulatory regions by DNA methyltransferases (…”
BackgroundThe new frontier in cancer research: Deciphering cancer epigenetics
Lohrum, M. A. E., Stunnenberg, H. G., & Logie, C. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.011 · Cited by 22
Metadata
- Authors
- Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- University of California, San Francisco (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Science
- Published
- 2003-04-18
- Volume
- 300
- Issue
- 5618
- Pages
- 489-492
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1990381590
- Cited by
- 1,499
- References
- 34
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 20 · 2023: 36 · 2022: 40 · 2021: 43 · 2020: 52 · 2019: 50 · 2018: 48 · 2017: 48 · 2016: 63 · 2015: 75 · 2014: 57 · 2013: 94 · 2012: 99
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- National Cancer Institute (R01CA087869, CA 87869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- DNA hypomethylation, DNMT1, T-cell lymphoma, tumor induction, epigenetic silencing, chromosomal instability, mouse model
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Alleles, Animals, Birth Weight, Cell Transformation, Neoplastic, Chromosome Aberrations, DNA (Cytosine-5-)-Methyltransferases, Heterozygote, Mice, Transgenic, Moloney murine leukemia virus, Trisomy, Virus Activation, Gene Rearrangement, Gene Rearrangement, beta-Chain T-Cell Antigen Receptor, Gene Expression, Gene Expression Regulation, Neoplastic, Genes, myc, Lymphoma, T-Cell, DNA Methylation, Loss of Heterozygosity, Endogenous Retroviruses, Chromosomes, Mammalian, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.